Average Co-Inventor Count = 4.30
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (8 from 3,687 patents)
2. E. R. Squibb Sons, Inc. (4 from 1,624 patents)
3. Other (1 from 832,966 patents)
4. Bristol-Myers Squibb (1 from 39 patents)
14 patents:
1. 7655689 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
2. 7517904 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
3. 7141578 - Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
4. 6953679 - Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
5. 6617323 - Amino-substituted compounds useful as inhibitors of IMPDH enzyme
6. 6455523 - Inhibitors of farnesyl protein transferase
7. 6420403 - Inhibitors of IMPDH enzyme
8. 6011029 - Inhibitors of farnesyl protein transferase
9. 5874578 - Process for preparing guanine-containing antiviral agents and purinyl
10. 5608064 - Purinyl salts useful for preparing guanine containing antiviral agents
11. 5306837 - Intermediates for an optically active cyclobutane nucleoside
12. 5256806 - Intermediates for the preparation of optically active cyclobutane
13. 5198583 - Optically active cyclobutane nucleoside and intermediates, therefor
14. 5064961 - Process for preparing an optically active cyclobutane nucleoside